Walton, C., King, R., Rechtman, L., Kaye, W., Leray, E., Marrie, R.A., and Robertson, N., La Rocca, N., Uitdehaag, B., van der Mei, I., Wallin, M., Helme, A., Angood Napier, C., Rijke, N., and Baneke, P., Rising prevalence of multiple sclerosis worldwide: Insights from the atlas of MS, Mult. Scler. J., 2020, vol. 26, no. 14, pp. 1816–1821. https://doi.org/10.1177/1352458520970841

Article  Google Scholar 

Dobson, R. and Giovannoni, G., Multiple sclerosis—a review, Eur. J. Neurol., 2019, vol. 26, no. 1, pp. 27–40. https://doi.org/10.1111/ene.13819

Article  CAS  PubMed  Google Scholar 

Axthelm, M.K., Bourdette, D.N., Marracci, G.H., Su, W., Mullaney, E.T., Manoharan, M., Kohama, S.G., Pollaro, J., Witkowski, E., Wang, P., Rooney, W.D., Sherman, L.S., and Wong, S.W., Japanese macaque encephalomyelitis: A spontaneous multiple sclerosis-like disease in a nonhuman primate, Ann. Neurol., 2011, vol. 70, no. 3, pp. 362–373. https://doi.org/10.1002/ana.22449

Article  PubMed  PubMed Central  Google Scholar 

Hedström, A.K., Hössjer, O., Katsoulis, M., Kockum, I., Olsson, T., and Alfredsson, L., Organic solvents and MS susceptibility. Interaction with MS risk HLA genes, Neurology, 2018, vol. 91, no. 5, pp. e455–e462. https://doi.org/10.1212/WNL.0000000000005906

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barinsky, I.F., Grebennikova, T.V., Alkhovsky, S.V., Kochergin-Nikitsky, K.S., Sergeyev, O.V., Gribencha, S.V., and Raev, S.A., Molecular genetic characteristics of the virus isolated from patients with human acute encephalomyelitis and multiple sclerosis, Probl. Virol., 2015, vol. 60, no. 4, pp. 14–18.

CAS  Google Scholar 

Buljevac, D., Flach, H.Z., Hop, W.C., Hijdra, D., Laman, J.D., Savelkoul, H.F., van Der Meche, F.G., van Doorn, P.A., and Hintzen, R.Q., Prospective study on the relationship between infections and multiple sclerosis exacerbations, Brain, 2002, vol. 125, pt. 5, pp. 952–960. https://doi.org/10.1093/brain/awf098

Kriesel, J.D., White, A., Hayden, F.G., Spruance, S.L., and Petajan, J., Multiple sclerosis attacks are associated with picornavirus infections, Mult. Scler., 2004, vol. 10, no. 2, pp. 145–148. https://doi.org/10.1191/1352458504ms1005oa

Article  PubMed  Google Scholar 

Cossu, D., Yokoyama, K., and Hattori, N., Bacteria–host interactions in multiple sclerosis, Front. Microbiol., 2018, vol. 9, p. 2966.https://doi.org/10.3389/fmicb.2018.02966

Article  PubMed  PubMed Central  Google Scholar 

Bjornevik, K., Cortese, M., Healy, B.C., Kuhle, J., Mina, M.J., Leng, Y., Elledge, S.J., Niebuhr, D.W., Scher, A.I., Munger, K.L., and Ascherio, A., Longitudinal analysis reveals high prevalence of Epstein–Barr virus associated with multiple sclerosis, Science, 2022, vol. 375, no. 6578, pp. 296–301. https://doi.org/10.1126/science.abj8222

Article  CAS  PubMed  Google Scholar 

Handel, A.E., Handunnetthi, L., Ebers, G.C., and Ramagopalan, S.V., Type 1 diabetes mellitus and multiple sclerosis: Common etiological features, Nat. Rev. Endocrinol., 2009, vol. 5, no. 12, pp. 655–664. https://doi.org/10.1038/nrendo.2009.216

Article  PubMed  Google Scholar 

Nielsen, N.M., Westergaard, T., Frisch, M., Rostgaard, K., Wohlfahrt, J., Koch-Henriksen, N., Melbye, M., and Hjalgrim, H., Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study, Arch. Neurol., 2006, vol. 63, no. 7, pp. 1001–1004. https://doi.org/10.1001/archneur.63.7.1001

Article  PubMed  Google Scholar 

Bechtold, S., Blaschek, A., Raile, K., Dost, A., Freiberg, C., Askenas, M., Fröhlich-Reiterer, E., Molz, E., and Holl, R.W., Higher relative risk for multiple sclerosis in a pediatric and adolescent diabetic population: Analysis from DPV database, Diabetes Care, 2014, vol. 37, no. 1, pp. 96–101. https://doi.org/10.2337/dc13-1414

Article  PubMed  Google Scholar 

Magyari, M. and Sorensen, P.S., Comorbidity in multiple sclerosis, Front. Neurol., 2020, vol. 11, p. 851. https://doi.org/10.3389/fneur.2020.00851

Article  PubMed  PubMed Central  Google Scholar 

Lapshtaeva, A.V., Abrosimova, Yu.G., Eremkina, T.Ya., and Kostina, Yu.A., Microbial agents as triggers of developing multiple sclerosis, Infektsiya i immunitet, 2021, vol. 11, no. 6, pp. 1050–1056. https://doi.org/10.15789/2220-7619-MAA-1656

Conway, S.E., Healy, B.C., Zurawski, J., Severson, C., Kaplan, T., Stazzone, L., Galetta, K., Chitnis, T., and Houtchens, M.K., COVID-19 severity is associated with worsened neurological outcomes in multiple sclerosis and related disorders, Mult. Scler. Relat. Dis., 2022, vol. 63, p. 103946. https://doi.org/10.1016/j.msard.2022.103946

Article  CAS  Google Scholar 

Najjar, S., Najjar, A., Chong, D.J., Pramanik, B.K., Kirsch, C., Kuzniecky, R.I., Pacia, S.V., and Azhar, S., Central nervous system complications associated with SARS-CoV-2 infection: Integrative concepts of pathophysiology and case reports, J. Neuroinflammation, 2020, vol. 17, no. 1, p. 231. https://doi.org/10.1186/s12974-020-01896-0

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sormani, M.P., Schiavetti, I., Carmisciano, L., et al., COVID-19 severity in multiple sclerosis: Putting data into context, Neurol. Neuroimmunol. Neuroinflamm., 2021, vol. 9, no. 1, p. e1105. https://doi.org/10.1212/NXI.0000000000001105

Article  PubMed  PubMed Central  Google Scholar 

Michelena, G., Casas, M., Eizaguirre, M.B., Pita, M.C., Cohen, L., Alonso, R., Garcea, O., and Silva, B.A., Can COVID-19 exacerbate multiple sclerosis symptoms? A case series analysis, Mult. Scler. Relat. Disord., 2022, vol. 57, p. 103368. https://doi.org/10.1016/j.msard.2021.103368

Article  CAS  PubMed  Google Scholar 

Lima, M., Aloizou, A.M., Siokas, V., Bakirtzis, C., Liampas, I., Tsouris, Z., Bogdanos, D.P., Baloyannis, S.J., and Dardiotis, E., Coronaviruses and their relationship with multiple sclerosis: Is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia?, Rev. Neurosci., 2022, vol. 33, no. 7, pp. 703–720. https://doi.org/10.1515/revneuro-2021-0148

Article  CAS  PubMed  Google Scholar 

Ximeno-Rodríguez, I., Blanco-delRío, I., Astigarraga, E., and Barreda-Gómez, G., Acquired immune deficiency syndrome correlation with SARS-CoV-2 N genotypes, Biomed. J., 2023, p. 100650. https://doi.org/10.1016/j.bj.2023.100650

Bauer, L., Laksono, B.M., de Vrij, F.M.S., Kushner, S.A., Harschnitz, O., and van Riel, D., The neuroinvasiveness, neurotropism, and neurovirulence of SARS-CoV-2, Trends Neurosci., 2022, vol. 45, no. 5, pp. 358–368. https://doi.org/10.1016/j.tins.2022.02.006

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stoiloudis, P., Kesidou, E., Bakirtzis, C., Sintila, S.-A., Konstantinidou, N., Boziki, M., and Grigoriadis, N., The role of diet and interventions on multiple sclerosis: A review, Nutrients, 2022, vol. 14, no. 6, p. 1150. https://doi.org/10.3390/nu14061150

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tarlinton, R.E., Khaibullin, T., Granatov, E., Martynova, E., Rizvanov, A., and Khaiboullina, S., The interaction between viral and environmental risk factors in the pathogenesis of multiple sclerosis, Int. J. Mol. Sci., 2019, vol, 20, no. 2, p. 303. https://doi.org/10.3390/ijms20020303

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fazia, T., Baldrighi, G.N., Nova, A., and Bernardinelli, L., A systematic review of Mendelian randomization studies on multiple sclerosis, Eur. J. Neurosci., 2023, vol. 58, no. 4, pp. 3172–3194. https://doi.org/10.1111/ejn.16088

Article  CAS  PubMed  Google Scholar 

Dhaiban, S., Al-Ani, M., Elemam, N.M., Al-Aawad, M.H., Al-Rawi, Z., and Maghazachi, A.A., Role of peripheral immune cells in multiple sclerosis and experimental autoimmune encephalomyelitis, Sci., 2021, vol. 3, no. 1, p. 12. https://doi.org/10.3390/sci3010012

Article  Google Scholar 

Theodosis-Nobelos, P. and Rekka, E.A., Efforts towards repurposing of antioxidant drugs and active compounds for multiple sclerosis control, Neurochem. Res., 2023, vol. 48, no. 3, pp. 725–744. https://doi.org/10.1007/s11064-022-03821-8

Article  CAS  PubMed  Google Scholar 

Nozari, E., Ghavamzadeh, S., and Razazian, N., The effect of vitamin B12 and folic acid supplementation on serum homocysteine, anemia status and quality of life of patients with multiple sclerosis, Clin. Nutr. Res., 2019, vol. 8, no. 1, pp. 36–45. https://doi.org/10.7762/cnr.2019.8.1.36

Article  PubMed  PubMed Central  Google Scholar 

Magyari, M. and Koch-Henriksen, N., Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis, J. Neurol. Neurosurg. Psychiatry, 2022, vol. 93, no. 7, pp. 716–722. https://doi.org/10.1136/jnnp-2022-328994

Article  PubMed  Google Scholar 

Salpietro, V., Polizzi, A., Recca, G., and Ruggieri, M., The role of puberty and adolescence in the pathobiology of pediatric multiple sclerosis, Mult. Scler. Demyelinating Disord., 2018, vol. 3, p. 2. https://doi.org/10.1186/s40893-017-0032-4

Book  Google Scholar 

Ostolaza, A., Corroza, J., and Ayuso, T., Multiple sclerosis and aging: Comorbidity and treatment challenges, Mult. Scler. Relat. Disord., 2021, vol. 50, p. 102815. https://doi.org/10.1016/j.msard.2021.102815

Article  PubMed  Google Scholar